In silico drug repurposing carvedilol and its metabolites against SARS-CoV-2 infection using molecular docking and molecular dynamic simulation approaches

C Zhang, J Liu, Y Sui, S Liu, M Yang - Scientific Reports, 2023 - nature.com
The pandemic of coronavirus disease 2019 (COVID-19) caused by the infection of severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a significant impact on …

Incidence of new-onset hypertension before, during, and after the COVID-19 pandemic: a 7-year longitudinal cohort study in a large population

V Trimarco, R Izzo, D Pacella, U Trama, MV Manzi… - BMC medicine, 2024 - Springer
Background While the augmented incidence of diabetes after COVID-19 has been widely
confirmed, controversial results are available on the risk of develo** hypertension during …

Long COVID: Long-Term Impact of SARS-CoV2

H Makhluf, H Madany, K Kim - Diagnostics, 2024 - mdpi.com
Four years post-pandemic, SARS-CoV-2 continues to affect many lives across the globe. An
estimated 65 million people suffer from long COVID, a term used to encapsulate the post …

Patients with type 1 diabetes are at elevated risk of develo** new hypertension, chronic kidney disease and diabetic ketoacidosis after COVID‐19: Up to 40 months' …

S Mehrotra‐Varma, JY Lu, MS Boparai… - Diabetes, Obesity …, 2024 - Wiley Online Library
Aim The aim was to investigate whether COVID‐19 increases new incidence of
hypertension (HTN), chronic kidney disease (CKD) and diabetic ketoacidosis (DKA) in …

Patients with unmet social needs are at higher risks of develo** severe long COVID-19 symptoms and neuropsychiatric sequela

A Eligulashvili, M Darrell, M Gordon, W Jerome… - Scientific reports, 2024 - nature.com
This study investigated long COVID of patients in the Montefiore Health System COVID-19
(CORE) Clinics in the Bronx with an emphasis on identifying health related social needs …

The potential clinical impact and cost-effectiveness of the updated COVID-19 mRNA fall 2023 vaccines in the United States

MA Kohli, M Maschio, K Joshi, A Lee… - Journal of Medical …, 2023 - Taylor & Francis
Aims To assess the potential clinical impact and cost-effectiveness of COVID-19 mRNA
vaccines updated for fall 2023 in adults aged≥ 18 years over a 1-year analytic time horizon …

Differences in the severity and mortality risk factors for patients hospitalized for COVID-19 pneumonia between the early wave and the very late stage of the pandemic

H Li, X Jia, Y Wang, Y Lv, J Wang, Y Zhai… - Frontiers in Medicine, 2023 - frontiersin.org
Background Since China's dynamic zero-COVID policy is cancelled on December 7, 2022,
the rapidly growing number of patients has brought a major public health challenge. This …

SARS-CoV-2 infection increases long-term multiple sclerosis disease activity and all-cause mortality in an underserved inner-city population

R Hadidchi, SH Wang, D Rezko, S Henry… - Multiple Sclerosis and …, 2024 - Elsevier
Background Although certain subsets patients with multiple sclerosis (MS), an immune-
mediated disorder, are at higher risk of worse acute COVID-19 outcomes compared to the …

Literature-Based Discovery to Elucidate the Biological Links between Resistant Hypertension and COVID-19

D Kartchner, K McCoy, J Dubey, D Zhang, K Zheng… - Biology, 2023 - mdpi.com
Simple Summary Given the prevalence of COVID-19 infection, assessment of sequelae is
critical to public health. Recent studies revealed a higher incidence of resistant hypertension …